OTHER INFORMATION
−Removed: During the three months ended March 31, 2026 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
+Added: During the three months ended June 30, 2026 , no director or officer, as defined in Rule 16a - 1 (f) under the Securities Exchange Act of 1934, as amended, of the Company adopted or terminated a "Rule 10b5 - 1 trading arrangement" or "non-Rule 10b5 - 1 trading arrangement," as each term is defined in Item 408 (a) of Regulation S-K.
Incorporated by Reference
15 unchanged sentences
Certificate of Designation of Series C-2 Preferred Stock
+Added: Certificate of Designation of Series C-3 Preferred Stock
+Added: Certificate of Designation of Series C-4 Preferred Stock
Certificate of Designation of Series D Preferred Stock
23 unchanged sentences
and the holders thereto
+Added: Securities Purchase Agreement, dated as of June 7, 2026, by and between Volato Group, Inc.
+Added: and Catheter Precision, Inc.
+Added: Registration Rights Agreement, dated as of June 7, 2026, by and between Volato Group, Inc.
+Added: and Catheter Precision, Inc.
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
CATHETER PRECISION, INC.
+Added: August 14, 2026
Executive Chairman of the Board and
1 unchanged sentence
(Principal Executive Officer)
+Added: August 14, 2026
/s/ Philip Anderson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.